Tag Archive for: STEAP1
Phase 1 Clinical Trial for ADRX-0405 in Advanced Solid Tumors Including Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxXaluritamig (AMG 509): Promising Updates on a STEAP1-Targeted Therapy for Advanced Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 3/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare alphafold antibody-drug conjugate apalutamide ARANOTE artificial intelligence ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy cancer treatment castration-resistant prostate cancer clinical trial clinical trials crispr darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology oncolytic virus p53 mutation personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 20/2025 May 18, 2025
- Real-World Prostate Cancer Treatments Are Better Than Clinical Trial Results, Study Finds May 17, 2025
- Innovations in Prostate Cancer Treatment: Antibody-Based Radioligand Therapy and Combinations Show Promise May 17, 2025
- CRISPR is Here to Stay: Gene Therapy Succesfully Used On An Infant With Incurable Disease May 16, 2025